Amgen Inc. (ETR:AMG)
239.05
+1.00 (0.42%)
Jun 25, 2025, 5:35 PM CET
Amgen Revenue
Amgen had revenue of $8.15B USD in the quarter ending March 31, 2025, with 9.43% growth. This brings the company's revenue in the last twelve months to $34.13B, up 15.56% year-over-year. In the year 2024, Amgen had annual revenue of $33.42B with 18.57% growth.
Revenue (ttm)
$34.13B
Revenue Growth
+15.56%
P/S Ratio
4.06
Revenue / Employee
$1.22M
Employees
28,000
Market Cap
128.30B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 33.42B | 5.23B | 18.57% |
Dec 31, 2023 | 28.19B | 1.87B | 7.09% |
Dec 31, 2022 | 26.32B | 344.00M | 1.32% |
Dec 31, 2021 | 25.98B | 555.00M | 2.18% |
Dec 31, 2020 | 25.42B | 2.06B | 8.83% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.14B |
Merck KGaA | 21.32B |
Bayer Aktiengesellschaft | 46.58B |
Fresenius SE & Co. KGaA | 22.13B |
Fresenius Medical Care AG | 19.49B |
Sartorius Aktiengesellschaft | 3.44B |
Carl Zeiss Meditec AG | 2.17B |
Fielmann Group AG | 2.33B |
Amgen News
- 5 days ago - Lilly, Novo, and Amgen set for key obesity trial readouts at upcoming ADA event - Seeking Alpha
- 7 days ago - Amgen Options Trading: A Deep Dive into Market Sentiment - Benzinga
- 7 days ago - Amgen to present data from mid-stage obesity study - Seeking Alpha
- 7 days ago - AMGEN'S PHASE 2 MARITIDE DATA TO BE PRESENTED AT THE AMERICAN DIABETES ASSOCIATION 85TH SCIENTIFIC SESSIONS - PRNewsWire
- 8 days ago - Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump's plan - CNBC
- 11 days ago - Amgen: Imdelltra Data And Q1 Results Impress - Seeking Alpha
- 15 days ago - Amgen Inc. (AMGN) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript - Seeking Alpha
- 16 days ago - Unpacking the Latest Options Trading Trends in Amgen - Benzinga